Inventor

SAINT-REMY JEAN-MARIE

BE36 patents

⚠️ This page may combine multiple inventors who share the name “SAINT-REMY JEAN-MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAINT-REMY JEAN-MARIE

IMCYSE SA

Peptides and methods for the treatment of diabetes

Peptides and methods for the treatment of diabetes

Immunogenic peptides and their use in immune disorders

Peptides and methods for the treatment of diabetes

Method for the detection, preparation and depletion of CD4+ t lymphocytes

Animal models for evaluating pharmaceutical compounds

Peptides and methods for the treatment of diabetes

Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif

Methods and compounds for eliminating immune responses to therapeutic agents

SAINT-REMY JEAN-MARIE

Immunogenic peptides and their use in immune disorders

Immunogenic control of tumours and tumour cells

Immunogenic peptides and their use in transplantation

Elimination of immune responses to viral vectors

Methods for treating or inhibiting thromboembolic disorders or for inhibiting coagulation

Antibodies which bind and inhibit blood factor VIII

Antibodies which bind and inhibit blood factor VIII

Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells

LIFE SCIENCES RES PARTNERS VZW

Elimination of immune responses to viral vectors

Factor VIII inhibitory antibodies with reduced glycosylation

Immunogenic peptides and their use in immune disorders

Immunogenic control of tumours and tumour cells

CD4+ T-cells with cytolytic properties

Immunotherapy targeting intracellular pathogens

Antibodies binding to the A2 domain of FVIII and inhibiting coagulation activity

SAINT REMY JEAN MARIE

Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination

Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells

Modulation of antigen immunogenicity by addition of epitopes recognized by NKT cells

IMNATE SARL

Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination

Coagulation factor VIII with reduced immunogenicity

LEUVEN RES & DEV VZW

Compound and method for the prevention and/or the treatment of allergy

INT INST CELLULAR MOLECUL PATH

Treatment of allergy and composition therefor

UNIV LEUVEN KATH

Modified epitopes for boosting CD4+ T-cell responses

BAXTER INT

Pharmaceutical composition and method for the suppression of factor VIII inhibitor production

BEHRENS CHRISTIAN

Anti-idiotypic antibody neutralizing the inhibitor activity of a factor VIII inhibitor antibody

COLLEN RES FOUNDATION

Composition and method for the prevention and/or the treatment of allergy

GILLES JEAN-GUY

Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII